Type 1 Diabetes (T1D) Special Statutory Funding Program
Research Consortia and Clinical Trials Networks
Trial to Reduce IDDM in the Genetically at Risk
The overall primary objective of this multi-center, international study is to determine whether weaning to a casein hydrolysate formula during the first 6-8 months of life in place of cow's milk based formula reduces the incidence of autoimmunity and type 1 diabetes in genetically susceptible newborn infants.
Website: trigr.epi.usf.edu/
Detailed Description: TRIGR.pdf
Research Resources Available to the Scientific Community:
Data/Sample Access Policies
After completion of the study, TRIGR will make available: (1) Data on growth and infant nutrition; (2) Serum and plasma specimens; (3) Data from genetic and laboratory analyses of stored samples.
Opportunities for New Investigators
Opportunities for new investigators are available at every TRIGR site. Please contact a TRIGR site near you for more information on opportunities.
Organizational/Committee Structures
Organizational Structure
Protocols: Human Investigation
Synopsis of protocol
Back to Alphabetical Listing of Consortia
Last Updated: January 11, 2006
